OrbiMed Capital GP IV LLC, 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 100,000 shares at $20.00 ($2.0M) on 2015-02-03, disclosed to the SEC on 2015-02-05.
Open-market purchase of $2.0M MRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| BOLD | SELL | 2018-03-12 | $10.2M | — | Filing → |
| BOLD | SELL | 2017-09-11 | $112K | — | Filing → |
| OTIC | SELL | 2015-11-24 | $5.7M | — | Filing → |